Please enable JavaScript.
Coggle requires JavaScript to display documents.
Anticancer Drugs, Pyrimidine Antimetabolites, Purine Antimetabolites -…
Anticancer Drugs
non-specific
Monoclonal Antibodies
Panitumumab
Ramucirumab
Daratumumab
Rituximab
Cetuximab
Trastuzumab
Bevacizumab
Alkylating Agents
Carmustine
Chlorambucil
Busulfan
Cyclophosphamide
Dacarbazine
Ifosfamide
Lomustine
Melphalan
Temozolomide
Tyrosine Kinase Inhibitors
Imatinib
Nilotinib
Idelalisib
Osimertinib
Ibrutinib
Pazopanib
Erlotinib
Sorafenib
Dasatinib
Sunitinib
Dabrafenib
Trametinib
Afatinib
Vemurafenib
Antibiotics
Daunorubicin
Doxorubicin
Epirubicin
Idarubicin
Mitoxantrone
Bleomycin
Others
Ixazomib
Lenalidomide
Nivolumab
Carfilzomib
Pembrolizumab
Bortezomib
Pomalidomide
Thalidomide
Platinum Coordination Complexes
Oxaliplatin
Carboplatin
Cisplatin
G1 Specific
Steroid Hormones
ER downregulator
Fulverstrant
Antiandrogens
Bicalutamide
Flutamide
Abiraterone
Nilutamide
SERMs
Tamoxifene
Raloxifene
Aromatase Inhibitors
Letrozole
Exemestane
Anastrazole
GnRH Agonists
Goserelin
Leuprolide
Triptorelin
Miscellaneous Agents
Asparaginase
Pegaspargase
Procarbazine
Interferons
Enzalutamide
Abiraterone
G2 specific
Topoisomerase Inhibitors
Irinotecan
Etoposide
Camptothecins
Topotecan
S specific
Antimetabolites
Pralatrexate
Azacitidine
Capecitabine
Pemetrexed
Cladribine
Methotrexate
Cytarabine
6-Mercaptopurine
Fludarabine
Gemcitabine
5-Fluorouracil
M specific
Microtubule Inhibitors
Paclitaxel
Vinorelbine
Vincristine
Vinblastine
Docetaxel
Pyrimidine Antimetabolites
Purine Antimetabolites